Post-TAVR risks examined in large cohort analysis

The transcatheter aortic valve replacement (TAVR) procedure replaces a narrow aortic valve that obstructs normal blood flow with a catheter. Three years ago an estimated 300,000 TAVRs had been performed. That number has climbed dramatically since and will continue with the recent FDA approval for expansion of TAVR procedures to even low-risk patients with severe […]

Vaughan-Sarrazin Awarded R01 Grant

Dr. Mary Vaughan-Sarrazin, Associate Professor of General Internal Medicine, has been awarded a three-year, $950,000 grant from the National Institutes of Health to evaluate the use of four FDA-approved anticoagulants for stroke prevention in individuals with atrial fibrillation (AF). Since 2010, dabigatran, rivaroxaban, apixaban, and edoxoban, which are collectively known as non-vitamin K oral anticoagulants (NOACs), have […]